Stay updated on Ibrutinib Combo in Recurrent HNSCC Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Updated the site’s displayed release/revision identifier from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T05:51:11.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.5.2 replaces the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:12:58.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Deleted Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T22:53:41.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Status indicators were updated to show 'Results Submitted' and 'Revision: v3.4.3'. The previous 'No Results Posted' and 'Revision: v3.4.2' indicators were removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:29:15.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the previous operating-status notice (Revision: v3.4.1) from the page.
    Difference
    0.4%
    Check dated 2026-02-11T04:49:19.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and a version update from v3.4.0 to v3.4.1 appear on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T03:27:53.000Z thumbnail image

Stay in the know with updates to Ibrutinib Combo in Recurrent HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.